115 related articles for article (PubMed ID: 10428529)
21. The effectiveness of hormone in relieving menopausal symptoms.
Panyakhamlerd K; Limpaphayom K; Taechakraichana N
J Med Assoc Thai; 1996 May; 79(5):273-7. PubMed ID: 8708517
[TBL] [Abstract][Full Text] [Related]
22. Oestrogen supplementation attenuates responses to psychological stress in elderly men rendered hypogonadal after treatment for prostate cancer.
Komesaroff PA; Fullerton M; Esler MD; Jennings G; Sudhir K
Clin Endocrinol (Oxf); 2002 Jun; 56(6):745-53. PubMed ID: 12072043
[TBL] [Abstract][Full Text] [Related]
23. [Evaluation the efficacy and safety of estradiol and drospirenone tablets in the treatment of menopausal symptoms among postmenopausal Chinese healthy women:a randomized, multi-center, double-blind, placebo-controlled clinical study].
Zhou YZ; Sun LZ; Lin JF; Yang X; Zhang LJ; Qiao J; Wang ZH; Xu YX; Xiong ZA; Lin SQ
Zhonghua Fu Chan Ke Za Zhi; 2011 May; 46(5):345-9. PubMed ID: 21733370
[TBL] [Abstract][Full Text] [Related]
24. A randomized, double-blind, placebo-controlled, crossover study on the effect of oral oestradiol on acute menopausal symptoms.
Chung TK; Yip SK; Lam P; Chang AM; Haines CJ
Maturitas; 1996 Oct; 25(2):115-23. PubMed ID: 8905602
[TBL] [Abstract][Full Text] [Related]
25. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.
Norman RJ; Flight IH; Rees MC
Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730
[TBL] [Abstract][Full Text] [Related]
26. Clinical study comparing the effects of sequential hormone replacement therapy with oestradiol/dydrogesterone and conjugated equine oestrogen/norgestrel on lipids and symptoms.
Cieraad D; Conradt C; Jesinger D; Bakowski M
Arch Gynecol Obstet; 2006 May; 274(2):74-80. PubMed ID: 16491367
[TBL] [Abstract][Full Text] [Related]
27. A randomized comparative study of the effects of oral and topical estrogen therapy on the lower urinary tract of hysterectomized postmenopausal women.
Long CY; Liu CM; Hsu SC; Chen YH; Wu CH; Tsai EM
Fertil Steril; 2006 Jan; 85(1):155-60. PubMed ID: 16412747
[TBL] [Abstract][Full Text] [Related]
28. Conservative treatment of urinary incontinence in women with special reference to the use of oestrogens.
Punnonen R; Kilkku P; Kiukko P; Rauramo L
Maturitas; 1981 Dec; 3(3-4):309-13. PubMed ID: 6278267
[TBL] [Abstract][Full Text] [Related]
29. Urinary incontinence: the role of menopause.
Trutnovsky G; Rojas RG; Mann KP; Dietz HP
Menopause; 2014 Apr; 21(4):399-402. PubMed ID: 24061048
[TBL] [Abstract][Full Text] [Related]
30. Effect of imipramine on urethral opening pressure: A randomized, double-blind, placebo-controlled crossover study in healthy women.
Kornholt J; Sonne DP; Riis T; Sonne J; Klarskov N
Neurourol Urodyn; 2019 Apr; 38(4):1076-1080. PubMed ID: 30843263
[TBL] [Abstract][Full Text] [Related]
31. Norfenefrine in the treatment of female stress incontinence. A double-blind controlled trial.
Lose G; Rix P; Diernaes E; Alexander N
Urol Int; 1988; 43(1):11-5. PubMed ID: 3287737
[TBL] [Abstract][Full Text] [Related]
32. Effect of methoxamine on maximum urethral pressure in women with genuine stress incontinence: a placebo-controlled, double-blind crossover study.
Radley SC; Chapple CR; Bryan NP; Clarke DE; Craig DA
Neurourol Urodyn; 2001; 20(1):43-52. PubMed ID: 11135381
[TBL] [Abstract][Full Text] [Related]
33. Pelvic floor electrical stimulation in the treatment of genuine stress incontinence: a multicenter, placebo-controlled trial.
Sand PK; Richardson DA; Staskin DR; Swift SE; Appell RA; Whitmore KE; Ostergard DR
Am J Obstet Gynecol; 1995 Jul; 173(1):72-9. PubMed ID: 7631730
[TBL] [Abstract][Full Text] [Related]
34. Comparison of treatment outcomes for imipramine for female genuine stress incontinence.
Lin HH; Sheu BC; Lo MC; Huang SC
Br J Obstet Gynaecol; 1999 Oct; 106(10):1089-92. PubMed ID: 10519437
[TBL] [Abstract][Full Text] [Related]
35. Low-Dose Intravaginal Estriol and Pelvic Floor Rehabilitation in Post-Menopausal Stress Urinary Incontinence.
Castellani D; Saldutto P; Galica V; Pace G; Biferi D; Paradiso Galatioto G; Vicentini C
Urol Int; 2015; 95(4):417-21. PubMed ID: 26043913
[TBL] [Abstract][Full Text] [Related]
36. The use of oestradiol therapy in postmenopausal women after TVT-O anti-incontinence surgery.
Liapis A; Bakas P; Georgantopoulou C; Creatsas G
Maturitas; 2010 May; 66(1):101-6. PubMed ID: 20236776
[TBL] [Abstract][Full Text] [Related]
37. The effect of continuous oestradiol with intermittent norgestimate on bone mineral density and bone turnover in post-menopausal women.
Arrenbrecht S; Caubel P; Garnero P; Felsenberg D
Maturitas; 2004 Jul; 48(3):197-207. PubMed ID: 15207885
[TBL] [Abstract][Full Text] [Related]
38. Five years with continuous combined oestrogen/progestogen therapy. Effects on calcium metabolism, lipoproteins, and bleeding pattern.
Christiansen C; Riis BJ
Br J Obstet Gynaecol; 1990 Dec; 97(12):1087-92. PubMed ID: 2126198
[TBL] [Abstract][Full Text] [Related]
39. Does sublingual 17 beta-oestradiol have any effects on exercise capacity and myocardial ischaemia in post-menopausal women with stable coronary artery disease?
al-Khalili F; Landgren BM; Eksborg S; Franco-Cereceda A; Schenck-Gustafsson K
Eur Heart J; 1998 Jul; 19(7):1019-26. PubMed ID: 9717036
[TBL] [Abstract][Full Text] [Related]
40. Hormone replacement therapy: I. A pharmacoeconomic appraisal of its therapeutic use in menopausal symptoms and urogenital estrogen deficiency.
Whittington R; Faulds D
Pharmacoeconomics; 1994 May; 5(5):419-45. PubMed ID: 10147233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
